Thomas Knösel

About Thomas Knösel

Thomas Knösel, With an exceptional h-index of 48 and a recent h-index of 33 (since 2020), a distinguished researcher at Ludwig-Maximilians-Universität München,

His recent articles reflect a diverse array of research interests and contributions to the field:

ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration

Current WHO classification (2022) of neuroendocrine neoplasms

Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After Adrenalectomy

Aktuelle WHO-Klassifikation (2022) neuroendokriner Neoplasien

Refusal of Adjuvant Therapies and Its Impact on Local Control and Survival in Patients with Bone and Soft Tissue Sarcomas of the Extremities and Trunk

Opposing effects of cannabidiol in patient-derived neuroendocrine tumor, pheochromocytoma/paraganglioma primary cultures

High-dose rate brachytherapy combined with PD-1 blockade as a treatment for metastatic adrenocortical carcinoma–a single center case series

The Effect of chemo-and radiotherapy on tumor necrosis in soft tissue sarcoma–does it influence prognosis?

Thomas Knösel Information

University

Position

___

Citations(all)

7693

Citations(since 2020)

4004

Cited By

5315

hIndex(all)

48

hIndex(since 2020)

33

i10Index(all)

131

i10Index(since 2020)

109

Email

University Profile Page

Ludwig-Maximilians-Universität München

Google Scholar

View Google Scholar Profile

Top articles of Thomas Knösel

Title

Journal

Author(s)

Publication Date

ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration

Molecular Oncology

Jennifer Kosinski

Antonio Sechi

Johanna Hain

Sophia Villwock

Stefanie Anh Ha

...

2024/2/20

Current WHO classification (2022) of neuroendocrine neoplasms

Oliver Buchstab

Thomas Knösel

2024/4/15

Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After Adrenalectomy

Hypertension

Martina Tetti

Denise Brüdgam

Jacopo Burrello

Aaron M Udager

Anna Riester

...

2024/2/6

Aktuelle WHO-Klassifikation (2022) neuroendokriner Neoplasien

Oliver Buchstab

Thomas Knösel

2024/4/15

Refusal of Adjuvant Therapies and Its Impact on Local Control and Survival in Patients with Bone and Soft Tissue Sarcomas of the Extremities and Trunk

Cancers

Franziska Mentrup

Alexander Klein

Lars Hartwin Lindner

Silke Nachbichler

Boris Michael Holzapfel

...

2024/1/5

Opposing effects of cannabidiol in patient-derived neuroendocrine tumor, pheochromocytoma/paraganglioma primary cultures

The Journal of Clinical Endocrinology & Metabolism

Katharina Wang

Laura Schober

Alessa Fischer

Nicole Bechmann

Julian Maurer

...

2024/4/12

High-dose rate brachytherapy combined with PD-1 blockade as a treatment for metastatic adrenocortical carcinoma–a single center case series

Hormone and Metabolic Research

Paul Schwarzlmueller

Stefanie Corradini

Max Seidensticker

Petra Zimmermann

Jochen Schreiner

...

2024/1

The Effect of chemo-and radiotherapy on tumor necrosis in soft tissue sarcoma–does it influence prognosis?

BMC cancer

Julian Fromm

Alexander Klein

Maya Kirilova

Lars Hartwin Lindner

Silke Nachbichler

...

2024/3/6

Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia

Genes & Diseases

Dongsheng Zhang

Wenjuan Tang

Haitao Niu

William Tse

Hai-Bin Ruan

...

2024/1/1

Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma

Clinical & Experimental Metastasis

Anton Burkhard-Meier

Vindi Jurinovic

Luc M Berclaz

Markus Albertsmeier

Hans Roland Dürr

...

2024/2/29

Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders

Anti-Cancer Drugs

Klara Dorman

Anton Burkhard-Meier

Dorit Di Gioia

Wolfgang G Kunz

Thomas Knösel

...

2023/2/1

TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)

Cancers

Luc M Berclaz

Annelore Altendorf-Hofmann

Lars H Lindner

Anton Burkhard-Meier

Dorit Di Gioia

...

2023/5/12

NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer

Journal of Cancer Research and Clinical Oncology

Viktoria Florentine Koehler

Josefine Achterfeld

Natalie Sandner

Christine Koch

Jonas Paul Wiegmann

...

2023/11

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F] SiTATE

Frontiers in Oncology

Ralf S Eschbach

Markus Hofmann

Lukas Späth

Gabriel T Sheikh

Astrid Delker

...

2023/1/30

Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms

Journal of Cancer Research and Clinical Oncology

Florian Bösch

Annelore Altendorf-Hofmann

Vanessa Koliogiannis

Harun Ilhan

Sven Jacob

...

2023/5

Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience

Journal of Cancer Research and Clinical Oncology

Luc M Berclaz

Anton Burkhard-Meier

Philipp Lange

Dorit Di Gioia

Michael Schmidt

...

2023/11

Thyroidal ACE2 protein expression and thyroid function tests in patients with COVID-19

Thyroid: Official Journal of the American Thyroid Association

Viktoria Florentine Koehler

Thomas Knösel

Sandra Elisabeth Hasmann

Clemens Scherer

Johannes C Hellmuth

...

2022/12/1

Case report: Extended Isolated Stopflow Limb Infusion (EISLI) for highly malignant osteosarcoma-complete pathological tumor remission and implantation of a knee joint prosthesis

International Journal of Surgery Case Reports

Kornelia Aigner

Emir Selak

Sabine Gailhofer

Thomas Knösel

Jayadeepa SrinivasRaju

...

2023/3/1

Diagnostic accuracy of SSR-PET/CT compared to histopathology in the identification of liver metastases from well-differentiated neuroendocrine tumors

Cancer Imaging

MP Fabritius

V Soltani

CC Cyran

J Ricke

P Bartenstein

...

2023/9/28

GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma

Gut

Mónica P de Andrés

Richard J Jackson

Irene Felipe

Sladjana Zagorac

Christian Pilarsky

...

2023/3/1

See List of Professors in Thomas Knösel University(Ludwig-Maximilians-Universität München)

Co-Authors

H-index: 66
Elisa Giovannetti

Elisa Giovannetti

Vrije Universiteit Amsterdam

H-index: 63
Hermeking, H

Hermeking, H

Ludwig-Maximilians-Universität München

H-index: 42
Professor Adam E. Frampton

Professor Adam E. Frampton

Imperial College London

H-index: 35
Leandro Castellano

Leandro Castellano

University of Sussex

H-index: 25
Christof Winter

Christof Winter

Technische Universität München

H-index: 10
Anna Emde

Anna Emde

Weizmann Institute of Science

academic-engine